IMV USA

IMV USA is a clinical-stage biopharmaceutical company. The company is committed to making immunotherapy more effective and broadly applicable for patients with cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that can control and prolong antigen exposure to the immune system.